XML 65 R54.htm IDEA: XBRL DOCUMENT v3.21.1
Note 11 - Related Party Transactions (Details Textual)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 01, 2020
USD ($)
shares
Oct. 01, 2017
USD ($)
Sep. 30, 2022
USD ($)
Jan. 31, 2017
CAD ($)
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2020
USD ($)
Dec. 14, 2017
Dec. 02, 2017
Jul. 12, 2017
Notes Receivable, Related Parties, Current         $ 17,901     $ 17,901      
Operating Lease, Liability, Total         $ 170,169            
Lease Arrangement, 20 North Rear Road [Member]                      
Operating Lease, Monthly Rent       $ 4,000              
Lessee, Operating Lease, Term of Contract (Year)       5 years              
Stock Issued During Period, Shares, Issued for Settlement of Lease Termination (in shares) | shares 36,500                    
Stock Issued During Period, Value, Issued for Settlement of Lease Termination $ 50,700                    
Lessee, Operating Lease, Discount Rate 8.00%                    
Operating Lease, Right-of-Use Asset $ 48,110                    
Operating Lease, Liability, Total 45,118                    
Gain (Loss) on Termination of Lease (53,692)                    
Operating Lease, Expense           $ 8,719          
Leases Office Space from R&D Labs Canada, Inc [Member]                      
Operating Lease, Monthly Rent   $ 2,608                  
Lessee, Operating Lease, Discount Rate         8.00%            
Operating Lease, Liability, Total         $ 170,169     164,997      
Operating Lease, Expense         5,172 6,325          
Operating Lease, Impairment Loss $ 146,795                    
Leases Office Space from R&D Labs Canada, Inc [Member] | Forecast [Member]                      
Operating Lease, Monthly Rent     $ 3,390                
Long-term Convertible Notes Payable to Multiple Private Investors [Member]                      
Debt Instrument, Interest Rate, Stated Percentage                     5.00%
CEN Biotech Ukraine [Member] | XN Pharma [Member]                      
Ownership Percentage                 49.00%    
CEN Biotech Ukraine [Member]                      
Percentage of Related Party's Equity Interest Owned by Director                 25.50%    
Business Acquisition, Percentage of Voting Interests Acquired                 51.00%    
Emergence Global [Member]                      
Notes Receivable, Related Parties, Current         $ 17,901     17,901      
Joseph Byrne [Member]                      
Percentage of Related Party's Equity Interest Owned         5.00%            
CEN Biotech Ukraine [Member]                      
Notes Receivable, Related Parties, Current         $ 17,901            
Due from Related Parties, Total         1,229,328     1,179,328      
Percentage of Related Party's Equity Interest Owned by Director                   51.00%  
CEN Biotech Ukraine [Member] | Equipment Sold to Related Party in Exchange for Note Receivable [Member]                      
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings             $ 255,141        
Notes Receivable, Related Parties             44,859        
Board Members and Officers [Member] | Consulting Fees [Member]                      
Related Party Transaction, Amounts of Transaction         31,200 $ 31,200          
Due to Related Parties, Total         $ 361,400     $ 330,200      
R&D Labs Canada, Inc [Member] | Purchased Equipment in Exchange for Note Payable [Member]                      
Notes Payable, Related Parties             $ 300,000